Hysterectomy Complications Rise After FDA Warns Against Morcellation

Performance of minimally invasive hysterectomies fell by 4% after the U.S. Food and Drug Administration first warned that using power morcellation to treat uterine fibroids during myomectomy or hysterectomy may pose a risk to patients with a hidden malignancy.
Reuters Health Information …read more